Reversal of multidrug resistance in cancer cells by Rhizoma Alismatis extract

Phytomedicine

Volumn 14, Issue 2-3, 2007, Pages 160-165

  Fong, W F ^a   Wang, C ^a   Zhu, G Y ^a   Leung, C H ^a   Yang, M S ^a   Cheung, H Y ^a  

^a CITY UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

HepG2 DR cells; K562 DR cells; Multidrug resistance; P glycoprotein; Rhizoma Alismatis

Indexed keywords

ALISMA ORIENTALIS EXTRACT; DACTINOMYCIN; DOXORUBICIN; GLYCOPROTEIN P; GLYCOPROTEIN P INHIBITOR; PACLITAXEL; PLANT EXTRACT; PUROMYCIN; RHODAMINE 123; UNCLASSIFIED DRUG; VERAPAMIL; VINBLASTINE;

ALISMA; ALISMA ORIENTALIS; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL LINE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG TRANSPORT; ENZYME SUBSTRATE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MITOSIS; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; RHIZOME;

ALISMA; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; HUMANS; INHIBITORY CONCENTRATION 50; P-GLYCOPROTEIN; PHYTOTHERAPY; PLANT EXTRACTS;

ALISMA;

EID: 33846397852     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2006.03.004     Document Type: Article

References (16)

1. Castaing M., Brouant P., Loiseau A., Santelli-Rouvier C., Santelli M., Alibert-Franco S., Mahamoud A., and Barbe J. Membrane permeation by multidrug-resistance-modulators and non-modulators: effects of hydrophobicity and electric charge. J. Pharmaceut. Pharmacol. 52 (2000) 289-296
2. Chan J.Y., Chu A.C., and Fung K.P. Inhibition of P-glycoprotein expression and reversal of drug resistance of human hepatoma HepG2 cells by multidrug resistance gene (mdr1) antisense RNA. Life Sci 67 (2000) 2117-2124
3. Chou T.C., and Talalay P. Analysis of combined drug effects: a new look at a very old problem. Trends Pharmacol. Sci. 4 (1983) 450-454
4. Chou T.C., and Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. In: Weber G. (Ed). Advances in Enzyme Regulation vol. 22 (1984), Pergamon Press, Oxford 27-55
5. Coley T.H. Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting P-glycoprotein. Cancer Control 10 (2003) 159-165
6. Gao X.J. Review on the explored calcium channel blockers in Chinese traditional medical herbs. Zhong Xi Yi Jie He Za Zhi (Chinese Journal of Integrated Traditional and Western Medicine) 10 (1990) 447
7. Giulio D., and Frances J.S. Interaction of combinations of drugs, chemosensitizers, and peptides with the P-glycoprotein multidrug transporter. Biochem. Pharmacol. 53 (1997) 1789-1797
8. Krishan A., and Ganapathi R. Laser flow cytometry and cancer chemotherapy: detection of intracellular antharcyclines by flow cytometry. J. Histochem. Cytochem. 27 (1979) 1655-1666
9. Lam W., Chan H., Yang M., Cheng S., and Fong W.F. Synergism of energy starvation and dextran-conjugated doxorubicin in the killing of multidrug-resistant KB carcinoma cells. Anticancer Drugs 10 (1999) 171-178
10. Ludescher C., Thaler J., Drach J., Spitale M., Gattringer C., Huber H., and Hofmann J. Detection of activity of P-glycoprotein in human tumor samples using rhodamine 123. Br. J. Haematol. 2 (1992) 161-168
11. Pascaud C., Garrigos M., and Orlowski S. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents. Biochem. J. 333 (1998) 351-358
12. Skenhan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J.T., Bokesch H., Kenney S., and Boyd M.R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 82 (1990) 1107-1112
13. Tarasiuk J., Stefanska B., Plodzich I., Tkaczyk-Gobis K., Seksek O., Martelli S., Garnier-Suillerot A., and Borowski E. Anthrapyridones, a novel group of antitumor non-cross resistant anthraquinone analogues, synthesis and molecular basis of the cytotoxic activity towards K562/DOX cells. Br. J. Pharmacol. 135 (2002) 1513-1523
14. Tashiro E., Simizu S., Takada M., Umezawa K., and Imoto M. Caspase-3 activation is not responsible for vinblastine-induced Bcl-2 phosphorylation and G2/M arrest in human small cell lung carcinoma Ms-1 cells. Jpn. J. Cancer Res. 89 (1998) 940-946
15. Yang C.P., Greenberger L.M., and Horwitz S.B. Reversal of multidrug resistance in tumor cells. In: Chou T.C., and Rideout D.C. (Eds). Synergism and Antagonism in Chemotherapy (1991), Academic Press, San Diego, USA 311-338
16. Zhou T.S., and Shi D.W. Review on the chemistry and pharmacology property of Rhizoma Alismatis. Zhong Cao Yao (Chinese Traditional and Herbal Drugs) 28 (1997) 125-127